BioCentury
ARTICLE | Company News

Angiogenesis Technologies Inc. deal

May 8, 1995 7:00 AM UTC

Angiogenesis received an exclusive worldwide license from Mount Sinai Hospital Corp. (Toronto) to technology that uses vanadate (salts and esters of vanadic acid) and related compounds to treat prolif...